Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)
China · Delayed Price · Currency is CNY 6.68
-0.07 (-1.04%)
Jun 11, 2026, 3:04 PM CST
SHE:300636 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 2,835 | 3,154 | 3,331 | 4,423 | 5,134 | 5,427 | |
Market Cap Growth | -6.98% | -5.33% | -24.67% | -13.86% | -5.39% | 87.27% |
Enterprise Value | 3,172 | 2,920 | 3,771 | 4,694 | 5,587 | 5,986 |
Last Close Price | 6.75 | 7.47 | 7.88 | 10.38 | 14.54 | 17.21 |
PE Ratio | 39.89 | 43.15 | 31.26 | 41.73 | 51.00 | 66.90 |
Forward PE | 33.75 | 25.03 | 19.68 | 33.46 | 36.12 | 43.57 |
PS Ratio | 3.43 | 3.81 | 4.39 | 6.12 | 7.13 | 9.16 |
PB Ratio | 1.19 | 1.33 | 1.44 | 1.99 | 3.89 | 6.11 |
P/TBV Ratio | 1.20 | 1.34 | 1.46 | 2.01 | 3.95 | 6.26 |
P/FCF Ratio | - | - | 22.41 | - | - | - |
P/OCF Ratio | 15.01 | 15.61 | 11.68 | 27.01 | 26.20 | 41.32 |
EV/Sales Ratio | 3.84 | 3.52 | 4.97 | 6.50 | 7.76 | 10.11 |
EV/EBITDA Ratio | 17.11 | 16.09 | 18.52 | 28.91 | 31.75 | 42.66 |
EV/EBIT Ratio | 63.08 | 56.93 | 42.05 | 50.02 | 50.81 | 67.02 |
EV/FCF Ratio | - | - | 25.36 | - | - | - |
Debt / Equity Ratio | 0.26 | 0.27 | 0.30 | 0.35 | 0.47 | 0.91 |
Debt / EBITDA Ratio | 3.30 | 3.49 | 3.44 | 4.71 | 3.47 | 5.75 |
Debt / FCF Ratio | - | - | 4.73 | - | - | - |
Net Debt / Equity Ratio | 0.14 | -0.07 | 0.14 | 0.09 | 0.36 | 0.73 |
Net Debt / EBITDA Ratio | 1.83 | -0.94 | 1.53 | 1.18 | 2.68 | 4.63 |
Net Debt / FCF Ratio | -3.61 | 1.92 | 2.10 | -3.77 | -4.09 | -2.21 |
Asset Turnover | 0.25 | 0.25 | 0.23 | 0.26 | 0.35 | 0.35 |
Inventory Turnover | 1.18 | 1.21 | 1.00 | 0.98 | 1.13 | 1.19 |
Quick Ratio | 0.52 | 1.42 | 0.98 | 0.93 | 0.41 | 0.71 |
Current Ratio | 1.82 | 2.19 | 2.08 | 1.71 | 1.32 | 1.78 |
Return on Equity (ROE) | 3.02% | 3.13% | 4.70% | 5.98% | 9.12% | 9.52% |
Return on Assets (ROA) | 0.93% | 0.97% | 1.71% | 2.14% | 3.30% | 3.31% |
Return on Invested Capital (ROIC) | 1.99% | 2.06% | 3.31% | 4.20% | 6.26% | 6.19% |
Return on Capital Employed (ROCE) | 2.00% | 1.90% | 3.20% | 3.70% | 6.50% | 5.80% |
Earnings Yield | 2.51% | 2.32% | 3.20% | 2.40% | 1.96% | 1.49% |
FCF Yield | -3.30% | -2.83% | 4.46% | -1.15% | -2.25% | -5.41% |
Dividend Yield | 0.60% | 0.54% | 0.51% | 0.39% | 0.31% | 0.23% |
Payout Ratio | 39.18% | 39.37% | 27.32% | 25.39% | 31.90% | 26.87% |
Buyback Yield / Dilution | -0.06% | -0.03% | -10.39% | -9.89% | -2.55% | -9.05% |
Total Shareholder Return | 0.54% | 0.51% | -9.89% | -9.51% | -2.24% | -8.82% |